3822832
Last Update Posted: 2022-12-01
Recruiting has ended
All Genders accepted | 18 Years-75 Years |
51 Estimated Participants | No Expanded Access |
Interventional Study | Does not accept healthy volunteers |
A Study in Patients With Atopic Eczema to Test How Effective BI 655130 is and How Well it is Tolerated
The primary objective of this trial is to investigate the safety, tolerability and efficacy of BI 655130 in patients with Atopic Dermatitis (AD) following repeated intravenous administrations compared to placebo.
Eligibility
Relevant conditions:
Dermatitis, Atopic
If you aren't sure if you meet the criteria above speak to your healthcare professional. Criteria may be updated but not reflected here, do not hesitate to contact the trial if you think are close to fitting criteria.
locations
Data sourced from ClinicalTrials.gov